Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dose relationship between GnRH antagonists and pituitary suppression

J Rivier1, G C Jiang, S L Lahrichi

  • 1Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, CA 92037, USA.

Human Reproduction (Oxford, England)
|November 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.

British journal of cancer·2024
Same author

Effect of yeast cell wall supplementation on intestinal integrity, digestive enzyme activity and immune traits of broilers.

British poultry science·2021
Same author

Challenges and outcomes in establishing a sentinel lymph node biopsy service for oral squamous cell carcinoma in a regional district specialist hospital.

The British journal of oral & maxillofacial surgery·2020
Same author

TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder.

Brain, behavior, and immunity·2020
Same author

The use of random forests modelling to detect yeast-mannan sensitive bacterial changes in the broiler cecum.

Scientific reports·2018
Same author

NaYbF<sub>4</sub> nanoparticles as near infrared light excited inorganic photosensitizers for deep penetration in photodynamic therapy.

Nanoscale·2017

Researchers developed novel gonadotrophin-releasing hormone (GnRH) analogues, including antagonists, with varying durations of action. These potent analogues show promise for future human applications, addressing limitations of current GnRH therapies.

Area of Science:

  • Endocrinology
  • Medicinal Chemistry
  • Pharmacology

Background:

  • The clinical utility of gonadotrophin-releasing hormone (GnRH) agonists is established, but potent GnRH antagonists with favorable safety profiles for human use are needed.
  • Current research focuses on developing novel GnRH analogues to overcome limitations such as side effects and poor solubility.

Purpose of the Study:

  • To design, synthesize, and evaluate novel linear and cyclic GnRH analogues (agonists and antagonists) for potential therapeutic applications.
  • To investigate structure-activity relationships to optimize potency, duration of action, and reduce adverse effects like histamine release.

Main Methods:

  • Synthesis and testing of several hundred GnRH analogues in various rat models.
  • Evaluation of histamine releasing activity, aqueous solubility, and duration of action (short, intermediate, long) following subcutaneous administration.

Related Experiment Videos

  • Utilized nuclear magnetic resonance (NMR), computational techniques, and advanced synthetic methods.

    • Main Results:

    • Identified GnRH analogues with varying durations of action ( <12h, 12-72h, >72h) in rats.
    • Some analogues exhibited high histamine releasing activity, while others showed poor solubility.
    • Developed mono- and dicyclic GnRH analogues with potency comparable to the most potent linear analogues.

    Conclusions:

    • Specific structural features likely confer resistance to degradation and elimination, enabling varied durations of action.
    • Further studies on side-chain requirements and the development of conformationally-similar peptidomimetics are warranted.
    • These findings pave the way for developing improved GnRH-based therapeutics.